EGFR and central nervous system cancer: High‐grade glioma without EGFR mutations showed increased vascular density22; however, due to reduced BMX/SOX923 activity and insufficient coverage of perivascular cells, the blood–brain barrier was highly disrupted, leading to hypoxia, necrosis and ischemia.